Long-term follow-up of efficacy of insulin pump in the treatment of children with type 1 diabetes mellitus.
- Author:
Hong-Xiu YANG
1
;
Xue-Fei LENG
;
Si-Cui HU
1
;
Cheng LI
1
;
Ling-Yan QIAO
1
;
Zhi-Hong CHEN
;
Tang LI
1
Author Information
1. Department of Pediatric Endocrinology, Qingdao Women and Children's Hospital, Qingdao, Shandong 266000, China.
- Publication Type:Journal Article
- MeSH:
Child;
Diabetes Mellitus, Type 1/drug therapy*;
Diabetic Ketoacidosis;
Follow-Up Studies;
Humans;
Insulins;
Retrospective Studies
- From:
Chinese Journal of Contemporary Pediatrics
2021;23(2):116-120
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the clinical effect of continuous subcutaneous insulin infusion (CSⅡ) versus multiple daily injection (MDI) on blood glucose control in children with type 1 diabetes mellitus (T1DM).
METHODS:A retrospective analysis was performed on the medical data of 91 children with T1DM who were treated with CSⅡ for more than 1 year and 75 children with T1DM who were treated with MDI. The two groups were compared in terms of glycosylated hemoglobin (HbA1C) and the recurrence of diabetic ketoacidosis (DKA) to evaluate the difference in the efficacy during the 3-year follow-up. A survey was conducted for the children in the CSⅡ group and their family members to investigate the degree of satisfaction with insulin pump.
RESULTS:There was no significant difference in age, sex, and course of diabetes between the CSⅡ and MDI groups at disease onset and in the first year, the second year, and the third year of follow-up (
CONCLUSIONS:Children with T1DM treated with CSⅡ have a better control of blood glucose than those treated with MDI, and children and their family members are satisfied with CSⅡ treatment. Therefore, it holds promise for clinical application.
